Category: Pfizer

Did a study just show that COVID-19 vaccines killed 14x more people than they saved?! Take a look at the viral claim, and find out what the facts really are!   Claim : COVID Vaccines Kill 14X More People Than They Saved! People are sharing an article (archive) by The…

The UK is home to several biotech hubs, including the famous ‘golden triangle’, made up of Oxford, Cambridge, and London. In fact, after a $700 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe, laying the…

The antibody-drug conjugate (ADC) field is witnessing an expansion in the variety of conjugation techniques, linker chemistry, and payloads being used, moving beyond traditional tubulin inhibitors to include novel mechanisms of action. Investments in ADC research continue to grow, with significant funding rounds and acquisitions. For example, Novo Holdings’ $105…

There hasn’t been a lot of hair loss treatment progress in the last twenty years. However several biotech companies are hot on the case and are getting tantalizingly close to the breakthrough that many patients hope for. With body dysmorphia magnified by the omnipresent digital world, psychiatrists have increasingly linked…

The past year saw a string of pipeline cuts and downsizing plans strike the biotech job market. Have layoffs spooked young professionals looking for a way into the industry, and does the employment landscape seem to be looking up this year? Employment in the life sciences industry had hit a…

The National Institutes of Health appears to be struggling to hide its dirty laundry on COVID-19 origins against a rash of leaks, congressional probes, and Freedom of Information Act requests, even when officials are determined to thwart sunlight. The ongoing exposure of their communications and actions isn’t the only thing…

Key Points bluebird bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. bluebird bio’s latest FDA approval, LYFGENIA, is a one-time treatment for sickle cell disease, which is priced around $3.1 million per…

On Friday, wastewater data from Biobot Analytics and the US Centers for Disease Control and Prevention (CDC) affirmed that the US has now reached its second-highest level of COVID-19 infections of the pandemic. It is anticipated that by midweek, rates of infections will reach 2 million per day with approximately…

The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech companies (2,840) and an R&D intensity added value of 17%, the U.S. remains a strong leader in the industry. But…

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the industry now embracing the technology, we take a look at five of the top AI drug discovery companies.  The…

Job Category Any CategoryJobInternshipWork from Home Job Type Any Job TypesFull-timePart-timeContractVolunteer Location Any CountryUKCanadaAustraliaPakistanIrelandGermanyUSASwedenNew ZealandMalaysiaRussiaNetherlandDubaiSwitzerlandJapanVietnamItalyDenmarkOnlineGeorgiaLatviaSingaporeChinaNetherlandsIndiaFranceBelgiumBrazilColombiaEuropeEstoniaThailandNorwayNigeriaQatarCambodiaUAESouth KoreaAustriaTurkeyworldwideADB CountriesIndonesiaSaudi Arabia Industry Any Industry athletic apparel and footwear Refugee AgencyAccredited registrarAeronauticsAerospaceAirlineappliance manufacturerArtificial Intelligencearts, entertainment, and recreation sectorAstronomical ResearchAutomationAutomativeAviationBankingBioinformaticsBroadcastingBusiness Administrationcar manufacturingchemicalCivic and Social OrganizationsCivil EngineeringConsumer goodsCreativity and Innovation DevelopmentCyber SecurityDairyingData analyticsDevelopmentDigitale-commerceEducationEducationElectric Power GenerationEnergyEngineeringEngineering Professional…

As we approach the end of the year, we are repeating our twenty most-read articles of 2023, in reverse order. This is number 2 and it was first published on March 22. I’VE grown increasingly frustrated about the way debate is controlled around the topic of origins of the alleged…

It has been a bumpy ride for biopharma to develop a vaccine for the potentially deadly respiratory syncytial virus (RSV), since the 1960s. As GSK and Pfizer battled it out earlier this year, with the former’s Arexvy vaccine crowned the first-ever RSV vaccine to hit the market, a mere few…

Key Points Question  What is the association of PIK3CA mutations, response to therapy, and outcome by hormone receptor (HR) status and intrinsic subtype among patients with ERBB2/HER2-positive early breast cancer (EBC) treated in a clinical trial? Findings  In this cohort study of 184 patients enrolled in the phase 3 trial…

Catalytic converters are an important part of a car’s emission system, and they can be recycled for scrap metal. Selling catalytic converter scrap can be a lucrative business, but there are a few things to consider in order to maximize prof…1968 Oldsmobile 442 Beautiful Vintage Convertible! 75,894km Specs: Engine Size…

Visiongain has published a new report entitled Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034: Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus, Others), by Application (Antisense and RNAi, Gene Therapy, Cell Therapy, Vaccinology), by End-use (Pharma and Biopharma Companies, Research Institutes), by Disease (Oncology, Genetic Disorders,…

Intradermal Injection Industry The value of the worldwide synthetic biology industry size was estimated at US$ 15.8 billion in 2022 and is projected to grow to around US$ 138.8 billion by 2032. Synthetic biology refers to redesigning organisms through engineering with the objective of improving development in health services and…

The following article originally appeared on Dr. Robert Malone’s Substack, and is reprinted here verbatim with permission. Robert Malone, MD, MS; Malone Institute December 15, 2023, 2:30 PM EST (Madison VA and Tallahassee FL) The failure of government regulatory authorities to identify and disclose DNA fragment contamination of…

There’s an air of cautious optimism about 2024, after a difficult few years following the end of the pandemic when investment in pharma and biotech research dropped substantially. After this significant reset, there’s now hope that in 2024, in line with emerging trends, the funds will be there for the…

Targeted therapy regimen, BRAFTOVI® (encorafenib) in combination with cetuximab, included on MOH Cancer Drug List, for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer who have received prior systemic therapy. BRAFTOVI in combination with cetuximab has been included on MOH CDL, for patients with BRAFV600E-mutant metastatic colorectal cancer…

Florida Surgeon General Dr. Joseph Ladapo As the federal government renews calls for more COVID-19 vaccines, the Biden administration continues to argue that the jabs are safe and effective, and said suggestions to the contrary, such as those recently expressed by Florida’s top doctor, amount to “misinformation and disinformation” that…

Thanks, Jan! Lets get this amplified! Go Joe Ladapo! t.co/kgaIolmKnR — Robert W Malone, MD (@RWMaloneMD) December 16, 2023 Someone said: “If reports I’ve read in the news are correct, that many high level members of the FDA are heavily invested in the covid vaccines, then it make sense that…

“Global Lipid Nanoparticles (LNPs) CDMO Market Focus on Nucleic Acids LNPs Segmented By Product (mRNA , Plasmid DNA (pDNA), siRNA, saRNA, microRNA, and Others), Scale Of Operation (Preclinical, Clinical , and Commercial), End-Users (Pharmaceutical Companies, Academic Research Institute, and Diagnostic Laboratories)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030.”…

Scientists win Nobel Prize for mRNA, COVID-19 work Dr. Katalin Karikó and Dr. Drew Weissman won the Nobel Prize in Physiology or Medicine for their work on mRNA vaccines, leading to a COVID vaccine. The claim: Moderna admitted mRNA vaccines cause cancer A Dec. 2 Instagram post (direct link, archive…

In response to a letter in which Florida Surgeon General Joseph Ladapo noted the detection of DNA fragments in mRNA COVID-19 vaccines, Peter Marks, director of the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research, emphasized the FDA’s view that the shots are safe and effective. “I…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hullo! Turns out Jay Bradner is moving from academia and Novartis to serve as Amgen’s new CSO. Also, the FDA has a new registry of trial sponsors and investigators…

Questioning the purity of mRNA COVID-19 vaccines is tantamount to spreading disinformation that kills people, the FDA’s top vaccines official not so subtly implied to Florida Surgeon General Joseph Ladapo this week. Ladapo notified FDA Commissioner Robert Califf and CDC Director Mandy Cohen Dec. 6 of recent research awaiting peer…

ABSTRACT Introduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology. Methods: We included exceptional responders and controls with advanced pancreatic cancer from Cleveland Clinic from April 2013 to August…

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascot, tidy up up the official…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business. The need-to-know this morning Apellis Pharmaceuticals said a…

Centers for Disease Control and Prevention Director Dr. Mandy Cohen traveled to Orlando this week as part of a nationwide tour to combat vaccine misinformation during respiratory disease season. Doctors this year are recommending a flu vaccine, an updated COVID-19 booster, and, for those who qualify, the newly available vaccine…

Pfizer execs said Wednesday that an ongoing cost-cutting plan will expand by $500 million, as the pharma giant looks to lower expenses ahead of its $43 billion Seagen integration and adjust for the post-COVID era.  In 2024, the drugmaker expects $4 billion in savings versus an original expectation of $3.5…

Abstract Cytochrome P450 enzymes including CYP2C19 and CYP2D6 are important for antidepressant metabolism and polymorphisms of these genes have been determined to predict metabolite levels. Nonetheless, more evidence is needed to understand the impact of genetic variations on antidepressant response. In this study, individual clinical and genetic data from 13…

Florida Surgeon General Joseph Ladapo | Photo courtesy of FDOH BY JENNIFER CABRERA TALLAHASSEE, Fla. – On December 6, Florida Surgeon General Joseph Ladapo sent a letter to the U.S. Food and Drug Administration (FDA), asking questions about a recent preprint documenting the detection of billions of DNA fragments per…

The European Commission has granted conditional marketing authorization to Elrexfio (elranatamab) to treat adults with multiple myeloma who received at least prior three lines of therapy and whose cancer has worsened since their last therapy. The indication covers patients on all 27 countries of the European Union, as well as…

Open Targets (OT) is a unique public-private partnership working to deliver experimental data and informatics platforms that enable researchers to make more informed decisions about target selection for drug discovery. OT is a shared initiative between the European Bioinformatics Institute (EMBL-EBI), a global leader in the management, integration and analysis…

The Middle East’s industry is rapidly growing, with several key players emerging in the region. Notably, Qatar, Saudi Arabia, and the United Arab Emirates (UAE) are at the forefront of this expansion. Our focus today zeros in on the UAE, particularly Dubai and its biopharma companies, renowned for being one…

Didn’t Happen Did Moderna admit that its COVID-19 mRNA vaccines cause cancer? No, that’s not true: Moderna made no such admission that its COVID mRNA vaccines are contaminated, nor that that they cause cancer or birth defects. There is no publicly available credible evidence that any mRNA vaccines cause cancer,…

bymuratdeniz/iStock/Getty Images Plus Florida’s Surgeon General, Dr. Joseph Ladapo, is seeking an explanation from federal health authorities on the undisclosed presence of potentially dangerous DNA fragments in mRNA Covid-19 injections. Ladapo sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Dr. Robert Califf and the U.S. Centers…

DNA Contamination of COVID Vaccines Explored in Journal of American Physicians and Surgeons TUCSON, Ariz., Dec. 11, 2023 (GLOBE NEWSWIRE) — The current controversy over the alleged DNA contamination of COVID-19 vaccines involves complex issues, and also shows the difficulties in arriving at truth in today’s polarized and politicized atmosphere,…

The ongoing patent battle between COVID-19 vaccine giants, Pfizer-BioNTech and Moderna, has seen a new development when the European Patent Office (EPO) invalidated one of Moderna’s patents related to “respiratory virus vaccines.” BioNTech, in collaboration with Pfizer and Sanofi, opposed the patent, leading to its invalidation. The European patent process…

PRESS RELEASE Published December 11, 2023   According to the report by Expert Market Research (EMR), the global red biotechnology market is projected to grow at a CAGR of 6.20% between 2024 and 2032. Aided by the escalating demand for therapeutic solutions, innovative drugs, and genetic engineering, the market is expected to…

“It’s hoped that [longer persistence with oral DEC-C] would translate to better outcomes because those patients are able to stay on a treatment that takes time to work,” said Amer Zeidan, MD, in a presentation during the meeting. Retrospective, real-world results showed that oral decitabine and cedazuridine (DEC-C) and standard…

BREAKING: Florida’s Surgeon General Joseph Ladapo has confirmed that fragments of DNA have been detected in COVID mRNA shots. What we’ve been saying about the COVID jab for years is finally coming to light. pic.twitter.com/IHZOVIFFgV — Dr. Simone Gold (@drsimonegold) December 10, 2023 More experts addressed the vaccines, saying that…

What could go wrong? The pioneer behind mRNA vaccines has revealed plans for a new vaccine that immunizes against cancer more than a decade before it strikes. pic.twitter.com/Am6B0wm0kr — Dr. Kat Lindley (@KLVeritas) December 9, 2023 Someone said: “First it will be 95% effective. Then 89%, then 77%, and so…

Marstacimab reduced annualized bleeding rate by 35% and 92% compared to routine prophylaxis and on-demand treatment in patients with hemophilia A and B without inhibitors, respectively Consistent reduction in bleeding rates observed after an additional 16 months of follow-up in the trial’s long-term extension observational study NEW YORK–(BUSINESS WIRE)– Pfizer…

Study design, ethical statement, and sample collection The vaccinated participants were recruited under the COVID-19 PROTECT study (2012/00917). The convalescent plasma samples were collected from subjects who were diagnosed with COVID-19 by positive polymerase chain reaction (PCR) results (study 2020/00120). All participants provided written informed consent in accordance with the…

(Reuters) — The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology. Casgevy, developed by partners Vertex Pharmaceuticals and CRISPR Therapeutics, and bluebird…

According to the reports in the media, the U.S. Food and Drug Administration (FDA) announced on Friday its approval of two gene therapies for sickle cell disease, marking a historic milestone in the treatment landscape. Notably, one of the approved treatments, Casgevy, employs the Nobel Prize-winning CRISPR gene editing technology,…

PRESS RELEASE Published December 7, 2023 DelveInsight’s, “Bladder Cancer Pipeline Insight 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bladder Cancer pipeline…

Results from the PARSIFAL-LONG study investigating endocrine-sensitive hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer demonstrated the efficacy of 2 combined option therapies, palbociclib (Ibrance; Pfizer) plus letrozole (Femara; Novartis) and palbociclib plus fulvestrant (Faslodex; Hikma), as first-line treatments for metastatic breast cancer. The study found no significant differences in progression-free survival…

New York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524) for Lyme disease vaccine candidate VLA15. The trial builds on previous positive Phase 1 and 2 trial results and includes both adult and…

Vlad Voiculescu, Romania’s minister of health between December 2020 and April 2021, has officially been charged with abuse of office and complicity in abuse of office in the case targeting the purchase of significantly more COVID-19 vaccine doses than necessary during the pandemic. Anticorruption (DNA) prosecutors started an investigation into…

PRESS RELEASE Published December 7, 2023 DelveInsight’s, “B-Cell Lymphoma Pipeline Insight 2023” report provides comprehensive insights about 160+ companies and 170+ pipeline drugs in B-Cell Lymphoma pipeline landscape. It covers the B-Cell Lymphomas pipeline drug profiles, including clinical and nonclinical stage products. It also covers the B-Cell Lymphomas pipeline therapeutics…

OTTAWA, ON, Dec. 8, 2023 /PRNewswire/ — The global in vitro diagnostics (IVD) market size is estimated to reach around USD 124.65 billion by 2032, increasing from USD 107.76 billion in 2023. The global in vitro diagnostics (IVD) market size was estimated at USD 115.48 billion in 2022 and the sector has…

CheckMate December 8, 2023 This week, we debunk viral social media posts that claim a new “genetic vaccine” has been added to the national vaccine schedule for children aged 2-6 months. We also show why the “mother of all revelations” was more fizzer than Pfizer, and identify some of the…

The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with…

Florida Surgeon General Joseph Ladapo, who notes that DNA fragments have been detected in mRNA COVID-19 vaccines, has issued a letter asking questions related to the issue. “On today’s episode of: What the FDA… I asked @DrCaliff_FDA to address the DNA fragments detected in mRNA COVID shots & how they…

PRESS RELEASE Published December 7, 2023 DelveInsight’s, “Glioma Pipeline Insight 2023” report provides comprehensive insights about 190+ companies and 130+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma pipeline therapeutics assessment by product…

Blau syndrome Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report provides an overview including definitions, applications, product launches, developments, challenges, and regions. It is predicted that the market will show strong development due to the driven consumption in various…

Market Overview and Report Coverage Anaplastic Large Cell Lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that primarily affects the lymph nodes and skin. It is characterized by the abnormal growth of large cells called anaplastic lymphoma kinase (ALK)-positive or ALK-negative lymphoma cells. The ALCL therapeutics market pertains to…

Joyce O’Shaughnessy, MD The addition of pembrolizumab (Keytruda) to neoadjuvant chemotherapy followed by adjuvant pembrolizumab plus endocrine therapy improved pathologic complete responses (pCRs) in patients with early-stage, high-risk, estrogen receptor (ER)–positive/HER2-negative breast cancer, including subsets defined by geography, stage, baseline clinical lymph node involvement, and PD-L1 expression, according to data…

Robert Mancini, PharmD, BCOP, FHOPA BMT/Heme Pharmacy Program Coordinator PGY2 Oncology Pharmacy Residency Director St. Luke’s Cancer Institute Boise, ID [Read Part 1] Targeted Oncology: Which bispecific T-cell engagers [BiTEs] are now available for use in hematologic malignancies? MANCINI: There are 6 BiTEs currently on the market; we didn’t include…

The National Anticorruption Directorate (DNA) announced on December 6 that it started the criminal investigation against former prime minister Florin Cîțu for complicity in abuse of office. The case targets the purchase of significantly more COVID-19 vaccine doses than necessary during the pandemic, although Romania could have used the opt-out…

Roche’s pitch to reset the standard of care in a breast cancer population has cleared a late-phase hurdle. The drugmaker’s attempt to improve on Novartis’ Piqray and deliver a first-line PI3K inhibitor has yielded an improved progression-free survival (PFS) in phase 3, teeing up talks with regulatory authorities.  The investigational…

Dive Brief: Pfizer and partner Valneva announced Monday that they have finished enrolling participants in a Phase 3 trial evaluating their experimental vaccine for Lyme disease. The announcement ends a lengthy delay that began in February, when the two companies said they were removing half of trial participants due to…

InsightAce Analytic Pvt. LTd. Companies covered in this report are Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, F. Hoffmann-La Roche Ltd., Myriad Genetics, Perkin Elmer, Caris Life Sciences, Partek, Inc., Eurofins Scientific, and Qiagen N.V., Foundation Medicine, Pacific Bioscience, Oxford Nanopore Technologies Ltd., Paradigm Diagnostics, Beijing Genomics Institute (BGI), Takara…

Authored by Maryanne Demasi via The Brownstone Institute, The recent findings of DNA fragments in the Pfizer and Moderna Covid-19 vaccines has led many to question why the FDA, which is responsible for monitoring the quality and safety of the vaccines, has failed to sound the alarm. For years, the FDA has…

9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and Europe in 2026 New York, NY, and Saint-Herblain (France), December 4, 2023 – Pfizer Inc. (NYSE:…

Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and…

9,437* participants enrolled at sites across the U.S., Europe and Canada in areas where Lyme disease is endemic Trial conclusion expected by year-end 2025 Pfizer aims to submit regulatory filings in the U.S. and Europe in 2026 New York, NY, and Saint-Herblain (France), December 4, 2023 – Pfizer Inc. (NYSE:…

A Reuters analysis finds that Novo Nordisk spent at least $25.8 million over the past decade on U.S. medical professionals to promote its two anti-obesity drugs. They money was party of the drugmaker’s campaign to convince U.S. doctors to prescribe Wegovy and persuade insurers to pay for it. Reuters: Maker…

Pfizer (NYSE:PFE), a global pharmaceutical giant, recently faced a setback in its quest to capture a significant share of the burgeoning weight loss drug market. The company announced its decision to discontinue the development of a twice-daily version of its experimental weight loss pill, danuglipron, following mixed results…

By Alex Philippidis At the start of 2023, the website for Pfizer CenterOne posted an article titled, “What Trends Will Shape the Pharma and Biotech Industries in 2023?” It quoted Rick L. Knight, the company’s global head of strategic account management, as follows: “We can continue to expect to see…

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. How sickle cell became the first CRISPR’d disease Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different…

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Clinical Oncology Next Generation Sequencing Market – (By Application Type (Screening, Companion Diagnostics, and Other Diagnostics), By End User (Hospitals, Clinics, and Laboratories), By Technology Type (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing…

A woman walks by Pfizer’s headquarters in New York City in a file image. (Kena Betancur/AFP via Getty Images) Pfizer and its partner BioNTech could be open to lawsuits for including a DNA sequence in their COVID-19 vaccine. The Public Readiness and Emergency Preparedness Act, known as the PREP Act,…

PRESS RELEASE Published December 1, 2023 The Lipid Nanoparticles CDMO Market (Nucleic Acids LNPs) worth $450.2 Mn by 2030 – Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” “Global Lipid Nanoparticles (LNPs) CDMO Market Focus on Nucleic Acids…

Pfizer, Inc. the world’s leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines (52.4%); - drugs for the treatment of cancer (15.2%); - cardiovascular, metabolic and analgesic drugs (11.5%); - injectable, anti-infectives drugs and active pharmaceutical ingredients (9%); - drugs for inflammatory and immune…

Pfizer Inc.’s stock tumbled 6% Friday, after the company said it would not move to a Phase 3 trial of a twice-daily formulation of a weight-loss drug after patients in an earlier study had a lot of side effects. The stock was on track for its biggest one-day percentage decline…

FREE Breaking News Alerts from StreetInsider.com! StreetInsider.com Top Tickers, 12/1/2023 December 1, 2023 6:57 AM EST Pfizer (NYSE: PFE) says twice-daily danuglipron formulation will not advance into Phase 3 studies Danuglipron demonstrated mean placebo-adjusted weight reductions ranging from -8% to -13% at 32 weeks and -5% to -9.5% at 26…

Embattled Texas Attorney General Ken Paxton is suing Pfizer, claiming the company unlawfully misrepresented the effectiveness of its COVID-19 vaccine and tried to censor public discussion of the vaccine.  Paxton said Pfizer engaged in a violation of the Texas Deceptive Trade Practice Act.  At issue was Pfizer and BioNTech saying…

PRESS RELEASE Published November 29, 2023 The research study conducted by Coherent Market Insights on the “Car T Cell Therapy Market” spans over 100 pages and delves into various facets of this market. It analyzes the business strategies adopted by emerging industry players, examines the geographical scope, dissects market segments,…

About the team/job We are looking for an enthusiastic and driven Backend Software Developer to join Open Targets at EMBL-EBI. We are open to applicants at different career stages, but we are keen to find someone who wants to embrace cutting-edge technologies in order to tackle complex challenges in drug…

Introduction In the US, dietary supplements (DS) are not subject to pre-market approval for safety and efficacy by the FDA.1 Post-market surveillance by the FDA has found increasing numbers of supplements to be adulterated or tainted, meaning that they contain undeclared or hidden, unapproved drug ingredients.2,3 These hidden ingredients have…

Authored by Tom Ozimek and Jan Jekielek via The Epoch Times (emphasis ours), Clinical pathologist Dr. Ryan Cole has said that DNA contamination in some COVID-19 vaccines may be related to an increase in cancers, micro-clotting, and autoimmune diseases. “My big concern is the fact that billions of people across…

Abstract The European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) is one of the world’s leading sources of public biomolecular data. Based at the Wellcome Genome Campus in Hinxton, UK, EMBL-EBI is one of six sites of the European Molecular Biology Laboratory (EMBL), Europe’s only intergovernmental life sciences organisation. This…

As per the report by Fortune Business Insights, The Biopharmaceuticals Market size is projected to reach USD 799.76 Billion by 2030, at a CAGR of 7.9% during the forecast period. Biopharmaceuticals Market Biopharmaceuticals Market (2023-2030) Pune, India, Nov. 27, 2023 (GLOBE NEWSWIRE) — The global biopharmaceuticals market size was USD…

Custom Market Insights The Global Gene Synthesis Market was at US$ 1,200 Million in 2022 and is growing to approx US$ 5,879 Million by 2032, with a CAGR growth of 19%, 2023 and 2032. The Global Gene Synthesis Market was estimated at USD 1,200 Million in 2022 and is anticipated…

GSK blood cancer drug Blenrep, withdrawn from the U.S. market just 12 months ago, may see renewed interest thanks to positive data from a combination trial. The Phase 3 study, dubbed DREAMM-7, showed that Blenrep, a BCMA-directed antibody drug conjugate (ADC), significantly extended the time to disease progression or death…

Data from several recent phase 3 trials support changes to standard care for non-small cell lung cancer (NSCLC), according to researchers. Results from the MARIPOSA trial suggest that amivantamab plus lazertinib represents a new first-line standard of care for patients with advanced, EGFR-mutant NSCLC.1 The MARIPOSA-2 trial suggests that amivantamab…

A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ No evidence that DNA sequence used in Pfizer…

FILE – A health worker administers a dose of COVID-19 vaccine during a vaccination clinic in Reading, Pa. On Friday, Nov. 24, 2023, The Associated Press reported on stories circulating online incorrectly claiming Pfizer’s COVID-19 vaccine contains a DNA sequence called Simian Virus 40 that can cause health problems, including…

Global Diffuse Large B-cell Lymphoma Therapeutics Market Forecast 2023-2032 The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company’s Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2023 identifies the increasing incidence…

On Sept. 9, 2021, Securitas posted a memo to employees advising that the federal government had announced that COVID-19 vaccination would be mandatory for employees in the air transport industry. As a result, Securitas employees were required to be fully vaccinated by the end of October 2021 and those who…

B-cell lymphoma, a subtype of non-Hodgkin lymphoma, stands as the leading cancer diagnosis in the United States, comprising 85% of all cases. This cancer targets the lymphatic system, encompassing lymph nodes, vessels, and related tissues responsible for fluid transportation within the body. The outlook for B-cell lymphoma patients has been…

SciCheck Digest The mRNA COVID-19 vaccines — like many other vaccines — can contain small amounts of DNA left over from the manufacturing process. There’s no evidence this residual DNA causes “turbo cancer,” or very aggressive cancer. Nor did Moderna admit that “mRNA Jabs Cause Turbo-Cancer,” contrary to an online…

Published: Nov 22, 2023 By Greg Slabodkin, Lori Ellis, Heather McKenzie Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) ⁠approved CRISPR/Cas9⁠ gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to…

Herpes Zoster Pipeline DelveInsight’s, “Herpes Zoster Pipeline Insight 2023,” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Herpes Zoster pipeline landscape. It covers the Herpes Zoster pipeline drug profiles, including Herpes Zoster clinical trials and nonclinical stage products. It also covers the therapeutics assessment by…

The US Food and Drug Administration (FDA) has approved the supplemental new drug application for Xtandi (enzalutamide) for the treatment of patients with nonmetastatic castration-sensitive prostate cancer (nmCSPC) and biochemical recurrence at high risk for metastasis.  The approval was based on data from the phase 3 EMBARK trial (ClinicalTrials.gov Identifier:…